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a  b s t r  a  c t
Introduction: Chronic stress can influence immune response to vaccines. Healthcare workers
are exposed to stressors and biological hazards, the  health effects of which may  be prevented
through vaccination.
Objectives: This study aims to evaluate the  association between stress in nurses and: (1)
insufficient response to influenza vaccine, assessed one month after vaccination (T1);  (2)
the  drop in haemagglutination-inhibition (HAI) antibodies (ab) six months after vaccination
(T6).
Methods: A nested case–control study was carried out with 136 healthy hospital nurses.
Individual interviews, the General Health Questionnaire (GHQ12) and Maslach Burnout Inventory
(MBI-HSS) were applied in order to determine the presence of stress, using the  triangulation
method at the  beginning of the  study (T0). Influenza vaccine was administered and titres
of HAI above each strain composing influenza vaccine before vaccination (T0),  at T1 and T6
were assessed.
Results: There was no statistically relevant (5%) relationship between stress and the  insuffi-
cient immune response to the vaccine at T1. Nevertheless, there was an  association between
stress and the drop in HAI ab AH1 at T6, when we  assessed stress by the triangulation method
using an interview (p =  0.006), GHQ12 (p  = 0.045) and combination of criteria (p = 0.001), even
after  multivariate analysis (respectively, p = 0.01, p < 0.05 and p = 0.002). The odds ratios were,
respectively, 3.64, 2.73 and 5.22.
Conclusions: The association we found, between chronic stress and the drop in HAI ab at
T6, corroborates the hypothesis that stress can negatively influence immune response.
Therefore, it seems reasonable to consider this issue when we implement vaccination
programmes for healthcare workers.
© 2013  Escola Nacional de Saúde Pública. Published by  Elsevier España, S.L. All rights
reserved.
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Profissionais de  saúde
Vacina contra a  gripe
Stresse
r  e s u m o
Introdução: O  stresse crónico pode influenciar a  resposta imunitária à vacinação.  Os profis-
sionais  de saúde estão expostos a stressores de natureza profissional e ainda a agentes
biológicos cujos efeitos poderão ser prevenidos pela vacinação.
Objetivos: Estudar a  associação entre a presença de stresse e  (1) a  “insuficiente” resposta
imunitária à  vacina contra a  gripe, avaliada um mês após a  vacinação (T1); (2)  a  redução dos
títulos de  anticorpos dirigidos às  hemaglutininas (HAI) seis meses após a  vacinação (T6).
Métodos:  Realizou-se um  estudo caso-controlo incorporado num estudo de coortes com a
participação de 136 enfermeiros hospitalares saudáveis. Realizaram-se entrevistas individu-
ais e  aplicaram-se os questionários The General Health Questionnaire (GHQ12) e Maslach Burnout
Inventory  (MBI-HSS) para determinação da presença  de  stresse crónico pelo método da
triangulação,  no início do estudo (T0).  Foi administrada a vacina contra a  gripe e  determinou-
se  os títulos de HAI dirigidos a cada estirpe componentes da vacina contra a  gripe, antes da
vacinação(T0), em T1 e em T6.
Resultados: Não se encontrou associação significativa (5%) entre a  presença  de stress e a
“insuficiente” resposta à  vacina contra a gripe em T1.  Contudo, encontrou-se uma  associação
entre a presença de stress e a  diminuição do título de  HAI dirigidos à  estirpe A(H1N1) em T6
quando se avaliou a  presença  de stresse pelo método da triangulação usando a entrevista
(p=0,006), o GHQ12 (p=0,045) e a  combinação dos três critérios (p=0,001), que se manteve após
análise  multivariada (respetivamente p=0,01, p<0.05 e  p=0.002). Os odds ratio ajustados foram
de  3,64, de 2,73 e  de 5,22.
Conclusões: A  associação encontrada entre a presença de  stresse crónico e a redução do
título de HAI em T6 vem apoiar a hipótese de que o stresse poderá influenciar negativa-
mente a manutenção dos títulos de anticorpos, mesmo em indivíduos adultos não idosos.
Assim, parece razoável considerar este aspeto quando se pretende implementar programas
de  vacinação dirigidos a  profissionais de saúde.
©  2013  Escola Nacional de Saúde Pública. Publicado por Elsevier España, S.L. Todos os
direitos reservados.
Introduction
Healthcare workers are exposed to many  stressors, some of
them related with organisational work conditions and others,
more  specific to this profession, related with their activity of
caring for the ill.1–3
Chronic stress and burnout seem to be  very common in
nurses.4–6 For example, López-Castillo and colleagues found
high levels of emotional disturbance determined by  the  Gen-
eral Health Questionnaire (GHQ28) in 39% of hospital nurses.7
Amongst the  consequences of chronic distress, whether
they are related or not with work, are the possible effects
on the immune system, including effects on the immune
response to vaccination.
Healthcare workers are strongly advised to be  vaccinated
against influenza in order to protect themselves against the
disease, reduce staff absenteeism and minimise the risk of
nosocomial transmission to  the patients they take care of.
Vaccination is a  possible model for immune response, test-
ing mostly the  humoral immune response. Vaccinated people
develop antibodies (ab) that bind and neutralise the  virus,
in most cases ab against the surface glycoprotein hemagglu-
tinin. Those ab can be used as  markers of protection against
the disease,8 caused by strains that are similar to the vaccine
composition.
According to meta-analysis by Segerstrom and Miller,
chronic exposure to stressors such as taking care of spouses
with dementia, unemployment and suffering from physi-
cal disability is  associated with a  smaller ab response to
influenza vaccine.9 Some reviews also suggest that chronic
stress is  associated with a smaller ab response to influenza
vaccine.10–12
Generally speaking, studies evaluating the association
between chronic stress and immune response to influenza
vaccine showed relatively consistent results in old people.
In those people, chronic exposure to stressors was  associ-
ated with chronic anxiety and symptoms of depression and a
lower response to influenza vaccine, in comparison to a con-
trol group.13–17
The use of a  standardized dose of antigen which promotes
a good immune response in most adults, could make it dif-
ficult the detection of the influence of chronic stress in the
immune response to vaccination in  younger adults, with a
robust immune system.
Older people have a weaker immune system, related with
age, so this could be  an explanation for the  greater con-
sistency of results showing a  negative association between
chronic stress and immune response to vaccines in them.
Vedhara and colleagues did  not find any association between
taking care of spouses with multiple sclerosis and ab
response to influenza vaccine in adults under the  age of 55.18
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However, those adults showed similar stress levels as  the con-
trol group.
In younger adults, such as university students, some
studies19–22 found an association between stress, charac-
terised in different ways,  and the  immune response to
influenza vaccine (assessed by ab titres or by response rate)
one month after vaccination. However, other studies did not
find that association.23–25
Some of the studies found an association between
stress and a  drop in ab titres assessed 4–6  months after
vaccination,19–23,25 even in the youngest adults. The drop in
the ab titres associated with stress was only observed against
one strain of vaccine components, suggesting that different
exposures or different past vaccinations can be responsible
for those results.
In an occupational context of healthcare settings, where
healthcare workers are in the labour market (and are there-
fore not very old), but are simultaneously exposed to chronic
stressors and biological risk hazards, it seems important to
study the influence of stress on immune response to influenza
vaccine.
Therefore, this study analyses the  association between
stress in nurses and: (1) insufficient response to influenza vac-
cine, assessed one month after vaccination (T1);  (2) the drop
in influenza aemagglutination-inhibition (HAI) ab titres six
months after vaccination (T6), as  compared to one month post
vaccination HAI ab titres.
Materials  and  methods
Study  design  and  participants
The study was a  nested case–control study, conducted over six
months in a  university hospital during the 2007/2008 influenza
season. Subjects were hospital nurses who  were not taking any
regular medication, including drugs that could affect immu-
nity (such as cancer therapy drugs or corticosteroids). They did
not have any medical condition that could affect the immune
response and they also had no major surgery in the preceding
three months. They did not have a  history of drug consump-
tion or alcohol consumption greater than 10  units per week,
nor did they handle citotoxic drugs or work regularly with
ionising radiation (n = 136). The hospital’s Ethics Committee
approved the study and all the participants signed their agree-
ment to participating in  it.
One-month and six-month drop-out criteria:
• clinical diagnosis of medical condition that may affect
immune response after the beginning of the study or taking
any regular medication that can affect immunity (assessed
by interview, at T1 and T6);
• workplace changes with regular exposure to ionising radia-
tions or citotoxic drugs handling;
• clinical influenza symptoms with virus identification in
nasal or oropharyngeal swab, during the six  months of the
study;
• a rise in HAI Ab titre to  A(H1N1),  A(H3N2)  or B strains six
months after vaccination, as  compared with the  titres mea-
sured one month after  vaccination. Such a  rise in HAI Ab
titre suggests an  exposure to influenza strains during T1 and
T6 instead of a delayed response to the vaccine.
Stress  assessment
Structured individual interviews were conducted at the begin-
ning of the  study (T0)  in order to:
• identify socio-demographic characteristics and possible
confoundable variables related with immunity (physical
exercise, nutritional parameters, nutritional supplements,
hours of sleep per day, smoking habits, shift work) and
influenza vaccination history;
• identify work-related and non-work-related stressors, using
a Likert scale from 1  to 5;
• assess perceived stress, using a Likert scale from 1 to 5;
• identify stress-related behavioural changes or psychoso-
matic symptoms.
We also applied the Portuguese versions of the General
Health Questionnaire (GHQ12) and Maslach Burnout Inventory
(MBI-HSS or MBI) exhaustion scale at the beginning of the
study (T0). Alfa Cronbach for those scales was 0.855 and 0.874
respectively.
In order to assess the presence of chronic stress, we applied
the triangulation method at T0, as  suggested by Cox and
colleagues,26 in four different ways:
• through interviews: we accepted the presence of chronic
stress using interviews if there were identified stressors
classified as  4 or  5, plus perceived stress classified as 4 or 5,
plus at least one behavioural change or one psychosomatic
symptom stress-related;
• through GHQ12: we  accepted the presence of chronic stress
using GHQ12 if there were identified stressors classified as  4
or 5, plus GHQ12 higher than 2, plus at least one behavioural
change or one psychosomatic symptom stress-related;
• through MBI: we accepted the presence of chronic stress
using MBI if there were identified stressors classified as  4 or
5, plus MBI exhaustion scale higher than 24, plus at least one
behavioural change or one psychosomatic symptom stress-
related;
• combination of criteria: we  accepted the presence of stress
using combination of criteria if there was  stress using inter-
view and stress using GHQ12 or if there was  stress using
interview and stress using MBI exhaustion scale.
Vaccination  and  laboratory  procedures
Venous blood was drawn at three stages between October
2007 and April 2008: (i)  immediately before influenza vacci-
nation (T0); (ii) one month following immunisation (T1); and
(iii) six  months after T0 (T6).
The samples rested 1 h at ambient temperature follow-
ing centrifugation at 3500 rpm for 10 min. Sera were stored at
−20 ◦C until used. All the samples drawn at T0, T1 and T6 were
processed at the same time and under the same conditions.
A  commercially available 2007/2008 trivalent influenza vac-
cine, with the recommended composition for that season in
North Hemisphere, was administered intramuscularly, in the
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deltoid muscle, during October. All the  vaccines belonged to
the same group (AFLUA290AD).
Haemagglutination inhibition reaction was used to  assess
specific HAI ab titre against influenza A(H1N1), A(H3N2)  and
B strains included in the influenza vaccine, in accordance
with  the World  Health Organisation’s manual.27 Immediately
before the laboratorial procedures, the sera were treated by a
Receptor-Destroying Enzyme (RDE) in  order to remove unspecific
agglutinins and inhibitors.
The reference antigens were diluted to obtain 4 units
against haemmaglutinin per 25 l  and incubated with the
treated sera samples. Erythrocytes were then added to
the fluid.
HAI Ab titre corresponded to  the inverse of the last  dilution
of serum that completely inhibited haemagglutination. We
used progressive dilutions, starting with 1:10 up to  1:20.480.
The serological parameters obtained were:
• HAI Ab titre against influenza A(H1N1),  A(H3N2)  and B
strains included in influenza vaccine, before (T0) and after
vaccination (T1 and T6);
•  rise in HAI Ab titre against influenza A(H1N1), A(H3N2) and B
strains included in influenza vaccine, assessed one month
after vaccination (compared to HAI Ab titre immediately
before vaccination);
• drop in HAI Ab titre against influenza A(H1N1), A(H3N2) and
B strains included in influenza vaccine, between T1 and T6.
Definitions
For analysis at T1 and at T6, we defined the following groups:
responders at T1 (one month after vaccination): participants
that showed, at T1, at least a fourfold rise in  HAI ab titre
compared to  the titre before vaccination;
non-responders at T1 (one month after vaccination): partic-
ipants that did not show, at T1, a fourfold rise in HAI ab titre
compared to  the titre before vaccination;
HAI ab titre drop group at T6 (six months after vaccination):
participants with at least a  fourfold rise in  HAI ab titre at T1,
but who  showed a  drop in HAI ab titre at T6, as  compared to
HAI ab titre at T1;
no change in HAI ab titre group at T6 (six months after vac-
cination): participants with at least a  fourfold rise in  HAI
ab titre at T1, but with no change in HAI ab titre at T6, as
compared to  HAI ab titre at T1.
Statistical  analyses
For dichotomous variables, we used the Qui-square and Fisher
exact tests and determined the odds ratio.
For numerical variables, we used the Kolmogorov–Smirnov
and Shapiro–Wilk tests to assess normal distribution in  non-
responders and responders (T1)  and in the HAI Ab titre drop
group and no change in HAI Ab titre group (T6).
For normal distributions, the  T Student test was  used
to compare means, and the Levene test to assess variance
homogeneity. For no normal distributions, we applied the
Mann–Whitney test to  compare medians.
We  also  used the  multivariate analysis and determined the
adjusted odds ratio for the confounding variables.
We  considered a  statistical significance of 5%.  All tests were
run in the Statistical Package for Social Sciences – SPSS® software,
version 14.0 for Windows.
Results
We  studied 136 nurses, most of whom were female (83.8%),
Caucasian (96.3%) and did not smoke (77.9%). Their average
age was  33 and the median age was  29 (22–63 years old). Only
one participant was more  than sixty years of age.
More than one half of the participants had been given an
influenza vaccine shot at least one  of the four seasons prior to
the beginning of the study (52.9%), mostly in  the year imme-
diately before (44.1%). Nurses included in the study worked
mostly on a  shift work basis (70.6%), had a  corporal index mass
(kg/m2) between 18.5 and 24.9 (72.1%) and slept at least 7 h per
day (66.2%). The majority did  not take vitamin supplements
(86.8%) or fish oil (98.5%). Only 54.4% did regular physical exer-
cise and 46.3% ate yogurt daily.
Association  between  chronic  stress  and  non-responders
at  T1
One month after vaccination (T1), we  did  not find any associ-
ation of statistical significance between non-responders for
A(H1N1) virus strain included in the influenza vaccine and
the presence of chronic stress at T0, assessed in four differ-
ent ways. Similarly, there was  also no association between
non-responders for A(H3N2) or non-responders for B strains
included in the influenza vaccine and chronic stress at T0. To
simplify the table, we named responders or non-responders
for A(H1N1)  and for A(H3N2) as responders or non-responders
AH1 and AH3 respectively (Table 1).
Aemagglutination-inhibition  antibodies  titres  at T0 in
responders and  non-responders  at T1
Using the Kolmogorov–Smirnov and Shapiro–Wilk tests, we found
that there is no normal distribution in non-responders and
responders at T1 for the considered continuous variables
(p < 0.001). Therefore, we  applied the Mann–Whitney test to
compare medians between HAI ab titres at T0 in  responders
and non-responders at T1. We found that non-responders
AH1 at T1 had significantly higher HAI ab AH1 titres at T0
than responders AH1 at T1. The same happened with non-
responders AH3 at T1 and non-responders B at T1, who  had
significantly higher HAI AH3 titres at T0 and HAI B titres at T0
than the corresponding responders (Table 2).
Association  between  chronic  stress  and  drop  in
aemagglutination-inhibition  ab  titres  at T6
At T6 (six months after vaccination), the presence of stress in
the HAI ab AH1 titre drop group was higher than in the  no
change in HAI ab AH1 titre group, when we assessed stress
by all the considered different ways, being statistically signi-
ficative when we  assessed the presence of chronic stress by
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Table 1 – Stress in  non-responders and in responders AH1, AH3 and B at T1.
HAI ab groups at  T1 Chronic stress
assessment
Stress in





n (%) n (%) OR (95% CI) p
AH1 (n =  135)
Non-responders: 45
Responders: 90
Stress (interview) 28  (62.2) 46  (51.1) 1.575 (0.759–3.272) 0.221
Stress (GHQ12)a 19  (42.2) 44  (48.9) 0.764 (0.371–1.572) 0.464
Stress (MBI)b 16  (35.6) 36  (40.0) 0.828 (0.394–1.738) 0.617
Stress (combination of  criteria)c 20  (44.4) 41  (45.6) 0.956 (0.466–1.963) 0.903
AH3 (n  =  136)
Non-responders: 50
Responders: 86
Stress (interview) 27  (54.0) 47  (54.7) 0.974 (0.484–1.961) 0.941
Stress (GHQ12)a 20  (40.0) 43  (50.0) 0.667 (0.329–1.351) 0.259
Stress (MBI)b 15  (30.0) 37  (43.0) 0.568 (0.271–1.190) 0.132
Stress (combination criteria)c 20  (40.0) 41 (47.7) 0.732 (0.361–1.483) 0.386
B (n = 135)
Non-responders: 59
Responders: 76
Stress (interview) 31  (52.5) 43  (56.6) 0.850 (0.429–1.683) 0.640
Stress (GHQ12)a 24  (40.7) 39  (51.3) 0.651 (0.327–1.293) 0.219
Stress (MBI)b 22  (37.3) 30  (39.5) 0.912 (0.453–1.836) 0.796
Stress (combination of  criteria)c 24  (40.7) 37  (48.7) 0.723 (0.364–1.437) 0.354
OR – odds ratio; 95% CI – 95% confidence interval.
a General Health Questionnaire (GHQ12).
b Maslach Burnout Inventory (MBI).
c Stress (interview and  GHQ12) or  stress  (interview and  MBI).
triangulation method at T0 using interviews, GHQ12 and the
combination of the three methods. On the contrary, we did  not
find any statistically significant association between the  oth-
ers HAI ab titre drop groups at T6 and the presence of chronic
stress (Table 3).
Association  between  other  possible  confounding  variables
and aemagglutination-inhibition  ab  AH1 titre  drop  group
at T6
Some conditions that can affect immunity could have been
possible confounding factors, when we considered the asso-
ciation between stress and the HAI ab AH1 titre drop group at
T6.  Using the Kolmogorov–Smirnov and Shapiro–Wilk tests, we
found that there is no normal distribution in HAI ab AH1 titre
drop group at T6 and in no change in HAI ab AH1 titre at T6 for
the considered continuous variables (p < 0.001). Therefore, we
applied the Mann–Whitney test to compare their medians.
The statistical analyses did not find any significant differ-
ence between groups at T6 for  the variables (continuous and
dichotomous) taken into consideration (Table 4).
Multivariate  analysis  and  adjusted  odds  ratios  for  stress,
age and  aemagglutination-inhibition  ab  AH1 titres  at  T0
and  T1 considering  aemagglutination-inhibition  ab AH1
titre  drop  group  at T6
Stress – assessed by interview, GHQ12 or using the combination
of the three methods – was  the exclusive variable associated
with HAI ab AH1 titre drop group at T6, but we  also took the age
variable into consideration in the multivariate analysis. That
option was  made because age is a  strong factor influencing
immunity and, in the simple analysis, the  median difference
between groups would be different if we considered a confi-
dence level of 90% (instead of 95%).
Furthermore, Beyer and colleagues showed that basal HAI
ab AH1 titres influence HAI ab AH1 titres one month after
Table 2 – HAI antibodies AH1, AH3 and B titres at T0 in  non-responders and in responders AH1, AH3 and B at  T1.
HAI antibodies at  T0 Non-responders at T1 Responders at T1 Statistical analysis (Mann–Whitney test)
Md (min–max) Md (min–max) Md differences p
HAI ab AH1 titres at T0 in
non-responders AH1 (n = 45)
and responders AH1 (n = 90) at
T1
640.0  (80–10,240) 20.0 (10–1280) 620.0 <0001
HAI ab AH3 titres at T0 in
non-responders AH3 (n = 50)
and responders AH3 (n = 86) at
T1
160.0  (10–5120)  20.0 (10–1280) 140.0 <0001
HAI ab B titres at T0 in
non-responders B (n  = 59)
and responders B (n = 76)  at T1
160.0  (20–10,240) 60.0 (10–640) 100.0 <0001
Md - median.
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Table 3 – Stress in HAI antibodies titre drop group and in no change in HAI Ab titre group AH1, AH3 and B at  T6.
HAI ab groups at T6 Chronic stress
assessment
Stress in HAI ab  titre
drop group  at  T6
Stress in no  change in
HAI Ab titre group at  T6
Statistical analysis
(Qui-square test)
n  (%) n (%)  OR (95% CI) p
AH1 (n = 88)
HAI ab titre drop
group: 57
No change in HAI ab
titre group: 31
Stress (interview) 36 (63.2) 10  (32.3) 3.600 (1.427–9.084) 0.006
Stress (GHQ12)a 33 (57.9) 11 (35.5) 2.500 (1.012–6.176) 0.045
Stress (MBI)b 25 (43.9) 10 (32.3) 1.641 (0.656–4.104) 0.288
Stress (combination
of criteria)c
34 (59.6) 7 (22.6) 5.068 (1.875–13.70) 0.001
AH3 (n = 81)
HAI ab titre drop
group: 48
No change in HAI ab
titre group: 33
Stress (interview) 25 (52.1) 21 (63.6) 0.621 (0.251–1.539) 0.302
Stress (GHQ12)a 26 (54.2) (51.5) 1.112 (0.458–2.703) 0.814
Stress (MBI)b 20 (41.7) 16 (48.5) 0.759 (0.311–1.851) 0.544
Stress (combination
of criteria)c
23 (47.9) 18 (54.5) 0.767 (0.315–1.865) 0.558
B (n = 76)
HAI ab titre drop
group: 51
No change in HAI ab
titre group: 25
Stress (interview) 26 (51.0) 17 (68.0) 0.489 (0.179–1.335) 0.160
Stress (GHQ12)a 27 (52.9) 12 (48.0) 1.219 (0.468–3.177) 0.686
Stress (MBI)b 17 (33.3) 13 (52.0) 0.462 (0.174–1.226) 0.118
Stress (combination
of criteria)c
22 (43.1) 15 (60.0) 0.506 (0.191–1.339) 0.167
OR – odds ratio; 95% CI – 95% confidence interval.
a General Health Questionnaire (GHQ12).
b Maslach Burnout Inventory (MBI).
c Stress (interview and  GHQ12)  or stress (interview and  MBI).
Table 4 – Variables distribution (stress not included) in HAI ab AH1 titre drop group at T6 and in no change in HAI ab AH1
titre group AH1 at T6.
Variables HAI ab  AH1 titre drop
group at T6 (n  = 57)
No  change in HAI ab
AH1 titre group at T6
(n = 31)
Statistical analysis (Fisher test or
Qui-square test or Mann–Whitney
test)
n  (%)  n  (%) OR (95% CI) p
Male gender 5 (8.8) 7  (22.6) 0.330 (0.095–1.145) 0.103a
Caucasian 53  (93.0) 31  (100) 0.631 (0.536–0.743) 0.293a
Shift work 35  (61.4) 23  (74.2) 0.553 (0.211–1.453) 0.250a
Daily sleep hours < 7 20  (35.1) 8  (25.8) 0.643 (0.244–1.699) 0.372b
Smokers 10  (17.5) 9  (29.0) 0.520 (0.185–1.461) 0.211b
Vitamin supplements 10  (17.5) 4  (12.9) 1.436 (0.410–5.025) 0.762a
Fish oil consumption 0 (0.0) 0  (0.0)
Daily consumption of yogurts 27  (47.4) 15  (48.4) 0.960 (0.400–2.304) 0.927b
No regular physical activity 29  (50.9) 11  (35.5) 1.883 (0.765–4.634) 0.166b
Past influenza vaccine 17  (29.8) 12  (38.7) 0.673 (0.268–1.687) 0.397b
Influenza vaccine at 2006 14  (24.6) 11  (35.5) 0.592 (0.229–1.533) 0.278b
HAI ab AH1 at T0 ≥  40 25 (43.9) 17  (54.8) 0.643 (0.267–1.551) 0.325b
Variables HAI ab  AH1 titre drop
group at T6 (n =  57)
No  change in HAI ab
AH1 titre group at T6
(n = 31)
Statistical analysis (Fisher test or
Qui-square test  or Mann–Whitney
test)
Md (min–max) Md (min–max) Md differences p
Age 31.0 (23.0–63.0) 26.0 (22.0–56.0) 5.0  0.072c
Body index mass 22.7 (17.7–37.8) 22.0 (18.0–37.5) 0.7  0.793c
HAI ab AH1 titres at  T0 20.0 (10–640) 40.0 (10–1280) −20.0  0.276c
HAI ab AH1 titres at T1 1280.0 (40–20,480) 1280.0  (160–20,480) 0.0  0.265c
Md –  median.
a Fisher test.
b Qui Square test.
c Mann–Whitney test.
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Table 5 – Multivaried analysis (multiple logistic regression) for stress (assessed by triangulation method using GHQ12,
using interview and using the combination of the three methods) in HAI ab AH1 titre drop group at T6 considering age,
HAI ab AH1 titres at  T0 and at T1.





Adjusted OR (95% CI) p
GHQ12 a
Age  1.038 (0.989–1.089) 0.134
Stress 2.733 (1.039–7.186) 0.042
HAI ab  AH1 at T0 0.998 (0.995–1.000) 0.100
HAI ab  AH1 at T1 1.000 (1.000–1.000) 0.793
Interview
Age 1.043 (0.994–1.094) 0.083
Stress 3.643 (1.371–9.684) 0.010
HAI ab  AH1 at T0 0.999 (0.996–1.001) 0.236




Age  1.044 (0.994–1.096) 0.087
Stress 5.223 (1.828–14.924) 0.002
HAI ab  AH1 at T0 0.999 (0.996–1.001) 0.255
HAI ab  AH1 at T1 1.000 (1.000–1.000) 0.892
Adjusted OR – adjusted odds ratio; 95% CI –  95% confidence interval.
a General Health Questionnaire (GHQ12).
b Stress (interview and  GHQ12) or  stress  (interview and  MBI).
vaccination.28 Therefore, we also considered HAI ab AH1 titres
at T0 and T1 in the multivariate analysis.
We  found that stress, assessed by triangulation method
using GHQ12,  using interview and using the combination of
the three methods, maintained the  association with HAI ab
AH1 titre drop group at T6. The association between HAI
ab AH1 titre drop group at T6 and the others variables did not
reveal any statistical significance (Table 5).
When we assessed stress by triangulation method using
GHQ12, the model was statistically significant (p < 0.029) and
suitable, given that null hypothesis was  not rejected in  the
Hosmer–Lemeshow test (p < 0.106). The model showed a valid-
ity rate of 65.9.
When we assessed stress by triangulation method using
interview, the model was statistically significant (p < 0.009) and
suitable, given that null hypothesis was  not rejected in  the
Hosmer–Lemeshow test (p < 0.761). The model showed a valid-
ity rate of 71.6.
When we assessed stress by triangulation method using
the combination of the three methods, the model was sta-
tistically significant (p < 0.002) and suitable, given that null
hypothesis was  not rejected in the Hosmer–Lemeshow test
(p <  0.679). The model showed a validity rate of 73.9.
Discussion  and  conclusions
When human beings are exposed to chronic stressors, they
may respond to them with neuroendocrine changes that
include the release of neuropeptides, monoamines and hor-
mones. Most of those substances are able to change the
immune cells behaviour.29
Psychological chronic stress can change antibody (ab) pro-
duction and kinetics after vaccination, in  particular after the
influenza vaccine is given to  elderly people who take care of
spouses with dementia.9–12
Various studies of elderly people have found an asso-
ciation between exposure to a  long-term stressor (such as
dementia spouse caregiving) and a  small proportion of them
who reached at least ab HAI titres that were fourfold what
they had before flu vaccination, assessed one month after
vaccination.13–15 Bereavement and marriage seem to  be asso-
ciated with antibody response to influenza vaccination in the
elderly as  well.17
In our study, as in some other studies involving young
adults,18,23–25 we did not find any association between the
presence of chronic stress in nurses and the proportion of
them that reach at least four times the ab HAI titre levels they
had before flu vaccination. On the contrary, other studies have
found an  association among perceived distress,19 life events,20
neuroticism21 and loneliness22 and the immune response to
flu vaccination, assessed one month or five weeks after.
It is possible that methodological issues can explain dis-
crepancies in  results verified in studies with younger groups,
such as: (1)  different ways of characterising independent vari-
ables; (2) samples with differing demographic characteristics
and dimensions; (3) differing histories of flu virus exposure.
With respect to the latter issue, our study found that non-
responders had significantly higher ab HAI AH1N1,  AH3N2 and
B titres at T0 than responder groups. Therefore, as  postulated
by Beyer and colleagues,28 ab HAI titres at T0, showed to be an
important confounding variable when studying the  relation-
ship between stress and immune response to  flu vaccine one
month after vaccination and must be considered.
Nevertheless, we  found an  association between the pres-
ence of chronic stress (measured in three different ways) and a
drop in  ab HAI (AH1N1) at T6. Other studies also found an asso-
ciation between distress,19,25 life events,20 life events weighed
with perceived stress,23 neuroticism,21 or loneliness22 and a
drop in ab HAI four to six  months after vaccination. Those
associations were found for at least one strain composing the
flu vaccine.
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Our study found a  large proportion of nurses with chronic
stress in the HAI ab AH1 titre drop group at T6, as compared
to the no change in  HAI Ab AH1 titre group at T6, when we
measured stress by triangulation method, using interview or
GHQ12 to assess perceived stress, and using the combination
of the three methods (as described in the  methods section). We
did not find any statistically significant association when we
assessed the presence of stress by the triangulation method
but using the MBI  exhaustion scale to measure perceived
stress. A possible explanation is the fact that the MBI exhaus-
tion scale measures specifically work-related stress and the
possible immunologic repercussions of chronic stress seem to
be independent of the stress source.
As described in other studies,19–23,25 the association
between stress and a  drop in ab HAI at T6 did not occur for
all the vaccine strains components.
Strain novelty can be an important factor in that analy-
sis, as argued by other authors.15,20 Pressman and colleagues,
for example, only found an association between stress and
a drop in HAI ab, four months after vaccination, for a strain
that was not included in  previous vaccinations the  partici-
pants received.25 In our study, the  exclusive strain that was
not included in  flu vaccines in  the three preceding years
was  the A(H1N1) strain.
In Portugal the  predominant circulating strains with high
flu activity since 1990 have been A(H3N2)  and B.  From 1990 to
the beginning of the study, the A(H1N1) strain was only pre-
dominant in 2005, simultaneously with strain B,  and 2005 was
a year with very low flu activity.30 We  also know that A strains
undergo more  drift mutations than B stains,31 so this can con-
tribute to their being a relative novelty for the participants’
immune system.
Finally, in our study, the A(H1N1)  influenza strain proved to
be the most immunogenic one, showing a rise in the HAI Ab
titre geometric mean of 11.1. A (H3N2)  and B strains showed
rises of 6.2 and 4.6 times, respectively, between T0 and T1.
It is possible that the best immunogenicity observed for the
A (H1N1) strain was related with the fact that some partici-
pants had had a primary infection with an  A (H1N1)  strain, so
the response to A  (H1N1)  antigens have been more  robust in
them.32 That could be a factor that may  influence the detec-
tion of the association between stress and drops in HAI ab after
a period of time.
Given that our sample was not a randomised sample
because it  depended on nurses voluntarily being vaccinated
and participating in  the study, we analysed distribution dif-
ferences for some variables in the HAI ab AH1 titre drop group
at T6 and the no change in HAI Ab AH1 titre group at T6 that are
not included in  drop out criteria. As there are a lot of variables
for which we  do not yet know if they can influence immu-
nity, we  studied those that are most referred to in the relevant
literature.33
We  did not find any differences in the distribution of
the studied variables in  the two groups at T6. Nevertheless,
we decided to include ab AH1 titres at T0, ab AH1 titres at
T1 and age in  multiple logistic regression. The reason for
including the first two variables was the strong suggestion in
literature that they can influence ab titres after vaccination
(immune response),28 even though we found no references to
the influence they have on a  drop in titres six months after
flu vaccination. Age is  strongly related with immunity33 but
we did not find any difference in terms of age between the
two groups considered at T6 at  the  significance level we con-
sidered (5%). If we considered a significance level of 10% the
result would be different. Hence, we also included age in
the multivariate analysis.
After the multivariate analysis, we still found an associ-
ation with statistical significance between the presence of
chronic stress and the  HAI ab AH1 titre drop group at T6, when
we assessed stress in three different ways, all of them using
the triangulation method, as suggested by Cox and colleagues,
as a  good way of measuring stress.26 Therefore, the relation-
ship that we found between chronic stress and a drop in HAI ab
at T6 supports the thesis that stress can negatively influence
HAI ab titres some months after flu vaccination even in people
in adults under the age of 60. As  we could notice, this is the first
study assessing the association between chronic stress and
immune response to influenza vaccine in healthcare workers,
who is an important target group for influenza vaccine. There-
fore, in an occupational health environment, it is reasonable
to consider the  possible interference of chronic stress with ab
titres when we implement vaccination programmes to prevent
biological occupational risks.
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